Turkish Archives of Pediatrics
Original Article

Clinical Course and Prognosis of Tubulopathies Characterized by Metabolic Alkalosis in Children

1.

Department of Pediatric Nephrology, Çukurova University, Faculty of Medicine, Adana, Turkey

2.

Department of Medical Genetics, Çukurova University, Faculty of Medicine, Adana, Turkey

Turk Arch Pediatr 2022; 57: 644-650
DOI: 10.5152/TurkArchPediatr.2022.22124
Read: 107 Downloads: 106 Published: 01 November 2022

Objective: Bartter syndrome and Gitelman syndrome are rare inherited tubulopathies characterized by hypokalemic, hypochloremic metabolic alkalosis. This study aimed to clarify the frequency of the phenotypic and genotypic subgroups, clinical features, long-term management, and prognosis of children diagnosed with Bartter syndrome and Gitelman syndrome in this study.

Materials and Methods: Twenty-seven patients with Bartter syndrome and 6 patients with Gitelman syndrome, who were followed up between 2004 and 2020 in a single center, were included in the study.

Results: The median age of diagnosis was 4 months in patients with Bartter syndrome and 174 months in patients with Gitelman syndrome. At the last follow-up, a total of 12 Bartter syndrome patients had chronic kidney disease with a mean 7.79 ± 4.73 years of age; 5 (18.5%) of these patients had chronic kidney disease stage 2, 5 (18.5%) had chronic kidney disease stage 3, and 2 (7.4%) had chronic kidney disease stage 5. Of the 5 patients with Bartter syndrome with chronic kidney disease stage 2, 2 had CLCNKB and 1 had SLC12A1 gene mutation. Also, CLCNKB mutation was detected in 2 of 5 patients with Bartter syndrome with chronic kidney disease stage 3. Finally, 2 patients with Bartter syndrome with chronic kidney disease stage 5 had BSND mutation in one and CLCNKB mutation in the other. Estimated glomerular filtration rates of all patients with Gitelman syndrome were normal at the last follow-up. There was no statistically significant association of development of chronic kidney disease with genetic mutation, nephrocalcinosis, prematurity, and hypokalemia.

Conclusion: Patients with Bartter syndrome and Gitelman syndrome may have a different clinical course due to the underlying genetic mutation. Bartter syndrome and Gitelman syndrome require lifelong treatment, and regular follow-up is important to prevent advanced-stage chronic kidney disease.

Cite this article as: Huseynli B, Atmış B, Cevizli D, Bişgin A, Bayazıt Karabay A. Clinical course and prognosis of tubulopathies characterized by metabolic alkalosis in children. Turk Arch Pediatr. 2022;57(6):644-650.

Files
EISSN 2757-6256